|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 272, Issue 6 1607-G1614, Copyright © 1997 by American Physiological Society
ARTICLES |
M. Tsukamoto, S. K. Sarna and R. E. Condon
Department of Surgery, Medical College of Wisconsin, Milwaukee, USA.
The role of tachykinins in stimulating phasic and giant migrating contractions (GMCs) in the normal and inflamed colon in conscious dogs was investigated by close-intra-arterial infusions of test substances. At low doses (0.1 nmol), substance P and neurokinin (NK1) receptor agonist ([Sar9,Met(O2)11]substance P] stimulated phasic contractions only. At higher doses (2.0 nmol), they stimulated phasic contractions and GMCs. The phasic contractions were blocked partially but significantly by prior close-intra-arterial infusions of tetrodotoxin and atropine but not by hexamethonium. NK1 receptor antagonist partially but significantly inhibited the phasic contractile response to substance P, whereas NK2 and NK3 receptor antagonists had no significant effect. The contractile response to NK2 receptor agonist was less than one-half of the response to substance P; NK3 receptor agonist did not stimulate any contractile activity. The stimulation of GMCs by higher doses of substance P was not blocked by prior infusions of atropine, tetrodotoxin, or NK1, NK2, and NK3 receptor antagonists, nor was the contractile response to substance P blocked by H1 and H2 receptor antagonists. Inflammation depressed the phasic contractile response but enhanced the stimulation of GMCs by substance P. The ability of substance P to stimulate GMCs is novel and suggests its potential role in increasing the frequency of these contractions during colonic inflammation.
This article has been cited by other articles:
![]() |
S. K. Sarna Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G572 - G581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sarna Molecular, functional, and pharmacological targets for the development of gut promotility drugs Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G545 - G555. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Guagnini, M Valenti, S Mukenge, I Matias, A Bianchetti, S Di Palo, G Ferla, V Di Marzo, and T Croci Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P Gut, July 1, 2006; 55(7): 946 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, C. Fiocchi, and V. E. Pricolo Production of IL-1{beta}, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1408 - C1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, M. D. Vrees, M. T. Kirber, C. Fiocchi, and V. E. Pricolo Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G833 - G843. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sarna Neuronal locus and cellular signaling for stimulation of ileal giant migrating and phasic contractions Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G789 - G797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Neunlist, P Aubert, C Toquet, T Oreshkova, J Barouk, P A Lehur, M Schemann, and J P Galmiche Changes in chemical coding of myenteric neurones in ulcerative colitis Gut, January 1, 2003; 52(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, C. P. Johnson, M. B. Adams, and S. K. Sarna Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G544 - G552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lecci, F. Carini, M. Tramontana, V. D'Aranno, E. Marinoni, A. Crea, L. Bueno, J. Fioramonti, M. Criscuoli, S. Giuliani, et al. Nepadutant Pharmacokinetics and Dose-Effect Relationships as Tachykinin NK2 Receptor Antagonist Are Altered by Intestinal Inflammation in Rodent Models J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 247 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sarna, A. Gonzalez, and R. P. Ryan Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G744 - G752. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Z. Shi and S. K. Sarna Impairment of Ca2+ mobilization in circular muscle cells of the inflamed colon Am J Physiol Gastrointest Liver Physiol, February 1, 2000; 278(2): G234 - G242. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lu, X. Qian, I. Berezin, G. L. Telford, J. D. Huizinga, and S. K. Sarna Inflammation modulates in vitro colonic myoelectric and contractile activity and interstitial cells of Cajal Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1233 - G1245. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |